From December 1, 2022 to February 28, 2023, the company has repurchased 30,000 shares, representing 0.03% for CAD 0.03 million. With this, the company has completed the repurchase of 30,000 shares, representing 0.03% for CAD 0.03 million under the buyback announced on November 30, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.84 CAD | -1.18% | +2.44% | +1.20% |
Jan. 29 | Cannara Biotech Inc. Reports Earnings Results for the First Quarter Ended November 30, 2023 | CI |
2023 | Cannara Biotech Inc. Reports Earnings Results for the Full Year Ended August 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
+1.20% | 55.24M | |
+31.96% | 272M | |
+33.74% | 261M | |
+49.42% | 194M | |
+44.98% | 131M | |
-28.57% | 121M | |
+115.91% | 119M | |
-42.17% | 119M | |
0.00% | 86.82M | |
+150.00% | 75.33M |
- Stock Market
- Equities
- LOVE Stock
- News Cannara Biotech Inc.
- Tranche Update on Cannara Biotech Inc.'s Equity Buyback Plan announced on November 30, 2022.